Sequent Scientific arm Alivira buys three companies in Europe

Alivira Animal Health Ltd, a subsidiary of Sequent Scientific Ltd, has forayed into the European veterinary pharmaceutical market with the acquisition of three companies - N-Vet AB, Fendigo SA and Fendigo BV.
 
Alivira has acquired 85 percent stake in the aforementioned companies with the current management retaining the balance stake. "The structure of the transaction permits the current management team to drive the business while Alivira would provide a stronger framework for growth through a larger product portfolio, backed by regulatory compliance, global reach and integrated manufacturing capabilities," said Sequent in a press release.
 
With three acquisitions, the company will establish its presence in Sweden, Belgium, Netherlands and Luxemburg.
   
Manish Gupta, managing director, Alivira, said, "The acquisitions give a fillip to Alivira’s vision to emerge as a power-house in the global animal health business. An established front-end presence available through these acquisitions will help us fast track the launch of our products in the European region. We are committed to further expanding our foot-prints in select market in the near future."
 
The acquired business collectively had revenues of $ 10 million in 2014 with an EBITDA margin of 13%.